retatrutide women results Experimental drug shows promising in trial Lilly's triple agonist, retatrutide, delivered

It is FDA-approved for managing type 2 diabetes and can be prescribed off-label for weight loss

Reactive Oxygen Species (ROS) and Advanced Oxidation Protein Products (AOPPs) in Podocyte Damage and Diabetic Nephropathy Pathogenesis Experimental studies have shown a direct link between increased ROS generation and podocyte damage

GLP-1 can cross the blood-brain barrier , where it reduces food intake and enhances insulin sensitivity by acting on regions like the hypothalamus

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder

For some patients, this blood pressure reduction eliminates the need for an additional antihypertensive medication